Traditional Beauty Retailers: Take a lesson from alternate channels.

Alternate retail channels are white hot in the beauty business, having grown sales nearly $1 billion since 2005. Instead of trying to figure out how to compete, traditional bricks-and-mortar brands should take a page from the alternate channel playbook and leverage these new opportunities to reach customers at their new favorite place to shop: at home. (Read more…)

Excipient Blends: the new frontier in oral pharmaceutical applications.

Excipients are the unsung heroes of the oral solid-dosage-form (OSDF) pharmaceutical industry. Most consumers are completely unaware of the critical role excipients play in delivering the beneficial medicines millions rely on to fight diseases and stay healthy. Yet it is the fillers, binders, disintegrants, lubricants, and coatings that ensure the accurate, timed delivery of drugs required to safely maintain optimum active ingredient levels in our system.

With average growth forecast to exceed 4% through 2015, the excipients market for OSDF is expected to keep pace with the 6% growth on the pharmaceutical horizon… (Read more…)

Live Summer Educational Series focusing on Personal Care, Home Care, and Healthcare

Join us for a series of LIVE EDUCATIONAL WEBINARS taking place in July! As we are nearing the completion of our most popular reports, we felt it would be a good time for us to share some of our findings with you. Therefore, we have scheduled a series of webinars for you to choose from. [...]

New Data Shows Plenty of Room for Innovators of All Sizes in OTC Market

The over-the-counter drug market is heating up as consumers turn increasingly toward self-medication in an effort to minimize out-of-pocket healthcare costs. With increasing competition from private-label products, blockbuster switches, and somewhat unconventional entries into the OTC drug business, new data reveals that while innovation doesn’t necessarily equate to superb business performance, there is plenty of [...]

Prominent OTC companies on hand at CHPA’s Market Exchange

Over-the-counter (OTC) medicines and                                                                        nutritional supplements play an increasingly vital role in America’s healthcare system. Sales continue to grow in spite of the recent recession, as customers seek cost-effective treatment options. Some OTC categories have even benefited from the economic downturn.

Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods

A number of costs associated with nonprescription drug manufacturing and marketing have increased over the past two and a half years. Certain material costs for plastic bottles and blister packs have risen by

Branded OTC Product Recalls

The largest OTC company, Johnson & Johnson’s McNeil Consumer Healthcare, has been plagued by a series of product recalls recently and this has widespread repercussions to the OTC industry. The problems have ranged from moldy odors and contaminated shipping palettes, to concerns about levels of active ingredients in products, and concerns about product safety and [...]

WEBINAR: OTC Drugs: U.S. Competitor Cost Structures 2010

Kline’s Health Industry Manager Laura Mahecha,will discuss key highlights from Kline’s recent research study on Over the Counter Drugs: U.S. Competitor Cost Structures 2010 in a Web conference, followed by a live question and answer session. REGISTER

WEBINAR – Nonprescription Drugs USA 2009 Key Highlights

Kline’s Healthcare Industry Manager Laura Mahecha will discuss current trends in the U.S. nonprescription drugs market in a web conference, followed by a live question and answer session. REGISTER Laura will share:

OTC Industry Looks to High-Growth OTC Switches to Fuel Industry Growth

Over the past few years, Rx-to-OTC switch products have emerged as a major growth driver in the U.S. OTC drug industry. While overall industry growth moderated to just 2.2% in 2008-2009, growth for Rx-to-OTC switches shot up by more than 12%. On the heels of numerous successful switches like Prevacid 24 Hour, Zegerid, Alli, and MiraLax, manufacturers have begun looking ahead at potential switch candidates much earlier in the Rx product life cycle. And with good reason: while the OTC market as a whole is expected to gain with just a CAGR of 2.6% over the next five years, future switches are set to explode by nearly 75%, adding more than $1.5 billion in absolute dollars to the OTC market.

Follow

Get every new post delivered to your Inbox.

Join 307 other followers